The government is also contemplating a separate policy for deep seated minerals such as diamond and gold
The global training centre has been specifically designed to provide practical training on the latest safety equipment and techniques
The order is approximately 31 percent of the company's total turnover in 2014-15
National Resource Facility for Bio-medical Research (NARF) will be built with an investment of Rs 338 cr by the Indian Council for Medical Research (ICMR)
Expansion follows a de-bottlenecking project undertaken by the company at an estimated cost of Rs 24 crores
The acquisition of Ecron Acunova will enable Take Solutions to add expertise in the areas of biosimilars, regenerative medicine and diagnostic imaging agents segments
The first initiative of its kind, IIL's mobile app is available for farmers, shopkeepers/dealers to help them get first hand and credible information on its products
The company claims jute polymers can be used in automobile parts, construction materials and cooking containers, thus giving a boost to Indian jute industry
The company will begin phase 2 clinical trial of saroglitazar, which is already marketed in India as Lipaglyn, in patients with severe hypertriglyceridemia in the US
As per the agreement, Dr Reddy's Labs gets the worldwide exclusive intellectual property rights for fondaparinux sodium, a generic version of the anticoagulant drug Arixtra
Invites flexible packaging company Uflex, which already has operations in Kentucky, to set up business in Virginia (USA)
Built with an investment of over Euro 1 billion, the plant will produce 300,000 metric tonnes per annum of TDI, a core component for polyurethanes
Integration of these two businesses will led to creation of the largest industrial gases company in the world
First Affordable Medicines and Reliable Implants for Treatment (AMRIT) outlet launched at AIIMs in New Delhi to sell drugs for the two ailments at highly discounted rates
Median cost per patient is 13.8 times higher for orphan drugs compared to non-orphan, states EvaluatePharma report
The company will also invest CHF 300 million to strengthen development and launch capabilities for specialised medicines at Kaiseraugst, Switzerland
The approval and launch of the montelukast granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market
With many of the bestselling patented brands approaching patent expiration, pharma companies are looking at various strategies to 'save' their brands
Carisoprodol tablets (250 mg and 350 mg) have sales of approximately $38 million
If combined with storage, solar rooftop power, which is already competitive compared to grid power, could be cheaper than grid power after 2022, says the new KPMG report